Agents for combating multiple drug resistance
US5114951A · kind A · utility
63Cited by
2References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 11, 1989 |
| Grant date | May 19, 1992 |
| Priority date | — |
| Expiry date | Apr 11, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Potentiating agents for combatting multiple drug resistance of susceptible tumor cells in a subject in need of such treatment are disclosed. The potentiating agents disclosed are triprolidine, cis-triprolidine, and pharmaceutically acceptable salts thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.